Apellis Pharmaceuticals Inc (APLS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Cedric Francois
Employees:
770
6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY 40014
502-241-4114

Apellis Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy (GA) in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases.

Data derived from most recent annual or quarterly report
Market Cap 9.717 Billion Shares Outstanding111.291 Million Avg 30-day Volume 1.464 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-6.29
Price to Revenue70.9341 Debt to Equity0.2252 EBITDA-671.95 Million
Price to Book Value18.2251 Operating Margin-605.0771 Enterprise Value6.837 Billion
Current Ratio6.883 EPS Growth0.208 Quick Ratio5.746
1 Yr BETA 0.704 52-week High/Low 94.45 / 37.66 Profit Margin-652.5966
Operating Cash Flow Growth-11.2075 Altman Z-Score3.2315 Free Cash Flow to Firm -502.516 Million
Earnings Report2023-08-07
View SEC Filings from APLS instead.

View recent insider trading info

Apellis Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding APLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APLS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-06-02 by LEWIS KAREN
  • 4: filed on 2023-05-25 by FRANCOIS CEDRIC
  • 4: filed on 2023-05-18 by MACHIELS ALEC
  • 4: filed on 2023-05-18 by FRANCOIS CEDRIC
  • 4: filed on 2023-05-09 by DESCHATELETS PASCAL
  • 4: filed on 2023-05-04 by TOWNSEND ADAM J.
  • 4: filed on 2023-04-28 by FRANCOIS CEDRIC
  • 4: filed on 2023-04-24 by WATSON DAVID O.
  • 4: filed on 2023-04-20 by FRANCOIS CEDRIC
  • 4: filed on 2023-04-20 by SULLIVAN TIMOTHY EUGENE

    • Events (8k)

  • 8-K: filed on 2023-06-01:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-03-15:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-24:
    Item 8.01: Other Events
  • 8-K: filed on 2022-08-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-19:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders

    • Proposed Sales (Form 144)

  • 144: filed on 2023-05-17:
  • 144: filed on 2023-05-16:
  • 144: filed on 2023-05-08:
  • 144: filed on 2023-05-03:
  • 144: filed on 2023-05-01:
  • 144: filed on 2023-04-18:
  • 144: filed on 2023-04-17:
  • 144: filed on 2023-04-17:
  • 144: filed on 2023-04-10:
  • 144: filed on 2023-04-03:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    107 Thousand total shares from 16 transactions

    Exercise Derivative Conversion (M)

    159.5 Thousand total shares from 12 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LEWIS KAREN CHIEF PEOPLE OFFICER

    • Officer
    		 41,504 2023-06-01 8

    FRANCOIS CEDRIC CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,846,223 2023-05-24 11

    MACHIELS ALEC

    • Director
    		 679,591 2023-05-17 13

    DESCHATELETS PASCAL CHIEF SCIENTIFIC OFFICER

    • Officer
    		 1,033,813 2023-05-08 19

    SULLIVAN TIMOTHY EUGENE CHIEF FINANCIAL OFFICER

    • Officer
    		 133,945 2023-05-03 6

    TOWNSEND ADAM J. CHIEF COMMERCIAL OFFICER

    • Officer
    		 75,995 2023-05-03 18

    WATSON DAVID O. GENERAL COUNSEL

    • Officer
    		 184,968 2023-04-21 7

    DUNLOP A. SINCLAIR

    • Director
    		 403,831 2023-04-03 14

    EISELE JEFFREY CHIEF DEVELOPMENT OFFICER

    • Officer
    		 53,883 2023-02-23 7

    SCHEIBLER LUKAS CHIEF RESEARCH OFFICER

    • Officer
    		 69,643 2023-02-21 5

    NICHOLSON NUR CHIEF TECHNICAL OFFICER

    • Officer
    		 63,503 2023-02-21 3

    CHOPAS JAMES GEORGE VP/CHIEF ACCOUNTING OFFICER

    • Officer
    		 30,863 2023-02-21 5

    DELONG MARK JEFFREY CHIEF BUSINESS & STRAT OFFICER

    • Officer
    		 51,341 2023-02-21 13

    BROWN VICTORIA L. PROGRAM TEAM LEAD

    • Officer
    		 23,556 2023-01-20 3

    GROSSI FEDERICO CHIEF MEDICAL OFFICER

    • Officer
    		 94,884 2023-01-05 6

    BAUMAL CAROLINE CHIEF MEDICAL OFFICER

    • Officer
    		 133 2023-01-03 3

    CHAN GERALD

    • Director
    		 15,538 2023-01-01 1

    O'BRIEN STEPHANIE MONAGHAN

    • Director
    		 15,538 2023-01-01 1

    FONTEYNE PAUL R.

    • Director
    		 20,538 2023-01-01 1

    MORNINGSIDE VENTURE INVESTMENTS LTD

    • 10% Owner
    		 12,806,342 2021-11-18 0

    PERRY NICOLE D VICE PRESIDENT - ACCOUNTING

    • Officer
    		 11,008 2021-08-02 0

    CELONA LUCIA SEE REMARKS

    • Officer
    		 5,213 2020-02-10 0

    LACKNER THOMAS A. SEE REMARKS

    • Officer
    		 7,725 2020-02-10 0

    SADR AHMAD SEE REMARKS

    • Officer
    		 2,725 2020-02-10 0

    AXON STEVEN CHIEF BUSINESS OFFICER

    • Officer
    		 50,110 2018-11-14 0

    GELLERT MICHAEL E

    • 10% Owner
    		 No longer subject to file 2017-11-13 0

    HILLHOUSE CAPITAL MANAGEMENT, LTD.

    • 10% Owner
    		 No longer subject to file 2017-11-13 0

    CORMORANT ASSET MANAGEMENT, LLC

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE GP, LLC

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    • Director
    • 10% Owner
    		 No longer subject to file 2017-11-13 0

    VENBIO GLOBAL STRATEGIC FUND II L.P.

    • 10% Owner
    		 No longer subject to file 2017-11-13 0

    AJU IB INVESTMENT CO., LTD.

    • 10% Owner
    		 No longer subject to file 2017-11-13 0

    CORMORANT ASSET MANAGEMENT, LLC

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND I, LP

    CHEN BIHUA

    • Director
    • 10% Owner
    		 0 2017-11-08 0

    POTENTIA HOLDINGS, LLC

    • 10% Owner
    		 3,826,601 2017-11-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-06-02 16:40:00 -0400 2023-06-01 M 5,000 d 106,000 direct yes

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-06-02 16:40:00 -0400 2023-06-01 S 5,000 $86.00 d 41,504 direct yes

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-06-02 16:40:00 -0400 2023-06-01 M 5,000 $34.11 a 46,504 direct yes

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-25 16:44:01 -0400 2023-05-24 G 20,000 d 274,655 direct -0.069 0.0 1 -0.069 2

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER indirect owner (the cedric francois irrevocable trust of 2023)

    		2023-05-25 16:44:01 -0400 2023-05-24 G 20,000 a 654,211 indirect -0.069 0.0 1 -0.069 2

    MACHIELS ALEC - Director

    		2023-05-18 17:12:45 -0400 2023-05-17 M 1,250 d 107,279 direct yes

    MACHIELS ALEC - Director

    		2023-05-18 17:12:45 -0400 2023-05-17 S 1,250 $88.66 d 267,641 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    MACHIELS ALEC - Director

    		2023-05-18 17:12:45 -0400 2023-05-17 M 1,250 $2.67 a 268,891 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-17 M 20,000 d 300,000 direct yes

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-17 M 20,000 $2.67 a 294,655 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 7,528 $87.02 d 276,775 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 934 $83.17 d 303,721 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 1,800 $83.85 d 301,921 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 2,120 $87.67 d 274,655 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 3,007 $85.90 d 284,303 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 S 14,611 $85.01 d 287,310 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 M 30,000 $2.67 a 304,655 direct yes -1.553 -2.1269 0.0 1 -4.1751 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-05-18 17:10:56 -0400 2023-05-16 M 30,000 d 320,000 direct yes

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-05-09 17:02:50 -0400 2023-05-08 M 18,500 d 109,994 direct yes

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-05-09 17:02:50 -0400 2023-05-08 M 18,500 $2.67 a 1,045,813 direct yes -3.1079 -2.3309 0.0 1 -4.049 5

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-05-09 17:02:50 -0400 2023-05-08 S 12,000 $92.39 d 1,033,813 direct yes -3.1079 -2.3309 0.0 1 -4.049 5

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-05-04 16:40:11 -0400 2023-05-03 M 5,000 d 282,500 direct yes

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-05-04 16:40:11 -0400 2023-05-03 S 5,000 $82.71 d 75,995 direct yes -1.9317 -5.6021 0.0 1 -5.6021 6

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-05-04 16:40:11 -0400 2023-05-03 M 5,000 $15.09 a 80,995 direct yes -1.9317 -5.6021 0.0 1 -5.6021 6

    SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER

    		2023-05-03 16:22:59 -0400 2023-05-03 G 20,000 d 77,713 direct 10.4421 4.9425 10.4421 2 0.0 1

    SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER indirect owner (the timothy e sullivan irrevocable trust of 2023)

    		2023-05-03 16:22:59 -0400 2023-05-03 G 20,000 a 56,232 indirect 10.4421 4.9425 10.4421 2 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER indirect owner (the cedric francois irrevocable trust of 2023 - 2)

    		2023-04-28 16:15:22 -0400 2023-04-27 G 382,946 a 382,946 indirect 0.2653 10.2026 12.3734 5 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-28 16:15:22 -0400 2023-04-27 G 382,946 d 274,655 direct 0.2653 10.2026 12.3734 5 0.0 1

    WATSON DAVID O. - Officer GENERAL COUNSEL

    		2023-04-24 16:20:30 -0400 2023-04-21 G 67,955 d 107,013 direct -3.1454 -4.9068 0.0 1 -5.3185 3

    WATSON DAVID O. - Officer GENERAL COUNSEL indirect owner (the david o. watson irrevocable trust of 2023)

    		2023-04-24 16:20:30 -0400 2023-04-21 G 67,955 a 67,955 indirect -3.1454 -4.9068 0.0 1 -5.3185 3

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-20 16:51:14 -0400 2023-04-19 M 20,000 d 350,000 direct yes

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-20 16:51:14 -0400 2023-04-19 M 20,000 $2.67 a 657,601 direct yes 2.9217 -3.2696 2.9217 2 -4.0232 5

    SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER

    		2023-04-20 16:15:17 -0400 2023-04-19 G 36,232 d 97,713 direct 2.9217 -3.2696 2.9217 2 -4.0232 5

    SULLIVAN TIMOTHY EUGENE - Officer CHIEF FINANCIAL OFFICER indirect owner (the timothy e sullivan irrevocable trust of 2023)

    		2023-04-20 16:15:17 -0400 2023-04-19 G 36,232 a 36,232 indirect 2.9217 -3.2696 2.9217 2 -4.0232 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-20 16:51:14 -0400 2023-04-18 M 30,000 d 370,000 direct yes

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-20 16:51:14 -0400 2023-04-18 S 30,000 $82.02 d 637,601 direct yes 2.9217 -3.2696 2.9217 2 -4.0232 5

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-20 16:51:14 -0400 2023-04-18 M 30,000 $2.67 a 667,601 direct yes 2.9217 -3.2696 2.9217 2 -4.0232 5

    MACHIELS ALEC - Director

    		2023-04-18 16:30:23 -0400 2023-04-17 M 1,250 d 108,529 direct yes

    MACHIELS ALEC - Director

    		2023-04-18 16:30:23 -0400 2023-04-17 S 1,250 $81.05 d 267,641 direct yes 0.3897 3.1299 6.333 13.4819 13 0.0 1

    MACHIELS ALEC - Director

    		2023-04-18 16:30:23 -0400 2023-04-17 M 1,250 $2.67 a 268,891 direct yes 0.3897 3.1299 6.333 13.4819 13 0.0 1

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-04-11 16:20:14 -0400 2023-04-10 M 18,500 $2.67 a 1,039,313 direct yes -0.6775 3.0238 8.6198 16.9134 18 -0.6775 2

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-04-11 16:20:14 -0400 2023-04-10 S 12,000 $78.21 d 1,027,313 direct yes -0.6775 3.0238 8.6198 16.9134 18 -0.6775 2

    DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

    		2023-04-11 16:20:14 -0400 2023-04-10 M 18,500 d 128,494 direct yes

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-05 17:56:20 -0400 2023-04-05 G 26,990 d 637,601 direct 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER indirect owner (the cedric francois irrevocable trust of 2023)

    		2023-04-05 17:56:20 -0400 2023-04-05 G 26,990 a 634,211 indirect 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-05 17:56:20 -0400 2023-04-04 G 380,000 d 664,591 direct 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER indirect owner (the cedric francois irrevocable trust of 2023)

    		2023-04-05 17:56:20 -0400 2023-04-04 G 380,000 a 607,221 indirect 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-04-05 16:50:25 -0400 2023-04-03 M 5,000 $15.09 a 80,995 direct yes 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-04-05 17:56:20 -0400 2023-04-03 G 227,221 d 1,044,591 direct 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    FRANCOIS CEDRIC - Director - Officer CHIEF EXECUTIVE OFFICER indirect owner (the cedric francois irrevocable trust of 2023)

    		2023-04-05 17:56:20 -0400 2023-04-03 G 227,221 a 227,221 indirect 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    DUNLOP A. SINCLAIR - Director

    		2023-04-05 16:54:53 -0400 2023-04-03 S 500 $74.05 d 131,297 direct yes 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-04-05 16:52:41 -0400 2023-04-03 M 5,000 d 111,000 direct yes

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-04-05 16:52:41 -0400 2023-04-03 S 5,000 $75.00 d 41,430 direct yes 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    LEWIS KAREN - Officer CHIEF PEOPLE OFFICER

    		2023-04-05 16:52:41 -0400 2023-04-03 M 5,000 $34.11 a 46,430 direct yes 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-04-05 16:50:25 -0400 2023-04-03 M 5,000 d 287,500 direct yes

    TOWNSEND ADAM J. - Officer CHIEF COMMERCIAL OFFICER

    		2023-04-05 16:50:25 -0400 2023-04-03 S 5,000 $74.05 d 75,995 direct yes 0.1396 2.7545 12.7951 18.2788 21 0.0 1

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 22:15:04 UTC 4.8007 0.2593 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 21:45:04 UTC 4.8007 0.2593 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 21:15:04 UTC 4.8006 0.2594 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 20:45:03 UTC 4.8006 0.2594 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 20:15:05 UTC 4.8006 0.2594 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 19:45:04 UTC 4.8006 0.2594 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 19:15:04 UTC 4.8006 0.2594 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 18:45:04 UTC 4.802 0.258 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 18:15:04 UTC 4.802 0.258 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 17:45:03 UTC 4.802 0.258 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 17:15:04 UTC 4.802 0.258 1700000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 16:45:03 UTC 4.8133 0.2567 1700000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 16:15:04 UTC 4.8133 0.2567 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 15:45:04 UTC 4.8133 0.2567 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 15:15:03 UTC 4.8133 0.2567 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 14:45:04 UTC 4.8133 0.2567 1500000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 14:15:03 UTC 4.8133 0.2567 1600000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 13:45:03 UTC 4.8083 0.2617 1600000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 13:15:04 UTC 4.8083 0.2617 1600000
    APELLIS PHARMACEUTICALS INC APLS 2023-06-02 12:45:03 UTC 4.8083 0.2617 1600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Trust for Professional Managers- Convergence Market Neutral Fund APLS -2152.0 shares, $-66346.16 2020-08-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund APLS -192.0 shares, $-5792.64 2020-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund APLS -777.0 shares, $-32696.16 2021-11-30 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund APLS -8614.0 shares, $-454216.22 2023-01-31 N-PORT
    Franklin Alternative Strategies Funds- K2 Alternative Strategies Fund APLS -11510.0 shares, $-753674.8 2023-02-28 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund APLS -2389.0 shares, $-157578.44 2023-03-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Strategic Equity Fund APLS -1720.0 shares, $-113451.2 2023-03-31 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund APLS -5996.0 shares, $-395496.16 2023-03-31 N-PORT
    JNL Series Trust- JNL Multi-Manager Alternative Fund APLS -28462.0 shares, $-1877353.52 2023-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund APLS -22300.0 shares, $-1470908.0 2023-03-31 N-PORT
    LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio APLS -9568.0 shares, $-631105.28 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments